Chubb: Life Science insurance in the era of pandemics

Life Science in the era of pandemics

A deep-dive into how Covid-19 is changing the risk landscape

Life science

Liability on the frontline

From fast-tracked clinical trials to emergency medical devices and telehealth innovations, the Life Sciences sector is providing solutions to Covid-19. This series of reports explores what risks organisations are entering into as they ride to the world’s rescue and how they can protect themselves  

Part 1: Emerging risks in Covid-19 clinical trials

With the scientific community throwing everything it has at Covid-19, best practice is slipping in clinical trials. What trade-offs are being made and who is liable? 

Document Icon Emerging risks in Covid-19 clinical trials

Part 2: Medical devices on a war footing

Consumer manufacturers pivoting to help in the fight against Covid-19 have been surprised by the liabilities they face in an unfamiliar sector. But even the specialist makers of ventilators, diagnostic tests and PPE have faced challenges, some of which will linger even after the pandemic is over 

Document Icon Report coming soon
Watch our videos to learn more about Masterpackage

Learn more about how Masterpackage can respond to your clients' specific exposures